← Leaderboards
Jason David Roh
Massachusetts General Hospital
$2,371,621
Attributed
$2,371,621
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $476.3K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,371,621 · 2
By mechanism
R01$1,399,621 · 1
K76$972,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Camille Elise Powe$7,616,107
- Joel S Finkelstein$18,947,740
- Andrew S Brack$7,229,827
- Lisa M Bebell$4,084,300
- Lee S Cohen$6,077,186
Others in their field
Other Emerging Leaders on “Myocardial Dysfunction”
- Barbara Halina Braffett · George Washington University$10,066,665
- Ionut Bebu · George Washington University$10,066,665
- Bing Yu · University Of Tx Md Anderson Can Ctr$7,842,501
- Kim-Lien T Nguyen · Va Greater Los Angeles Healthcare System$5,861,342
- Nuo Sun · Ohio State University$4,995,546
- R N Bryan · University Of Pennsylvania$4,847,313
Research focus
Myocardial DysfunctionPathologicHeart FailureMissionInnovationLoss Of FunctionCellsCohortHeart DiseasesHeartHeart FunctionHypertrophyInsightAutomobile DrivingActivin ACardiovascular DiseasesBiologicalAgingEtiologyCardiacFunctional DisorderBiologyBiology Of AgingPathway Interactions
Grant awards (7)
Placental Senescence in Peripartum Cardiomyopathy$465,334
R01 · FY2025 · HL · contact PI
Placental Senescence in Peripartum Cardiomyopathy$457,978
R01 · FY2024 · HL · contact PI
Placental Senescence in Peripartum Cardiomyopathy$476,309
R01 · FY2023 · HL · contact PI
Activin type II receptor activity in age-related frailty and heart failure$243,000
K76 · FY2022 · AG · contact PI
Activin type II receptor activity in age-related frailty and heart failure$243,000
K76 · FY2021 · AG · contact PI
Activin type II receptor activity in age-related frailty and heart failure$243,000
K76 · FY2020 · AG · contact PI
Activin type II receptor activity in age-related frailty and heart failure$243,000
K76 · FY2019 · AG · contact PI